Eli Lilly Shares Outstanding 2012-2026 | LLY

Eli Lilly shares outstanding for the quarter ending March 31, 2026 were 0.896B, a 0.52% decline year-over-year.

  • Eli Lilly 2025 shares outstanding were 0.899B, a 0.53% decline from 2024.
  • Eli Lilly 2024 shares outstanding were 0.904B, a 0.09% increase from 2023.
  • Eli Lilly 2023 shares outstanding were 0.903B, a 0.15% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

Eli Lilly Shares Outstanding 2012-2026 | LLY

  • Eli Lilly 2025 shares outstanding were 0.899B, a 0.53% decline from 2024.
  • Eli Lilly 2024 shares outstanding were 0.904B, a 0.09% increase from 2023.
  • Eli Lilly 2023 shares outstanding were 0.903B, a 0.15% decline from 2022.

Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Johnson & Johnson (JNJ)$574.4B
AbbVie (ABBV)$367.7B
Roche Holding AG (RHHBY)$318.8B
Merck (MRK)$299.9B
Novartis AG (NVS)$294B
Novo Nordisk (NVO)$167.5B
Pfizer (PFE)$153.1B
Sanofi (SNY)$114B
Bayer (BAYRY)$46.2B
Innoviva (INVA)$1.8B